Literature DB >> 1562049

Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase.

N Weidner1, R F Horan, K F Austen.   

Abstract

The factor(s) that causes excessive mast cell (MC) proliferation in indolent forms of mastocytosis is not known, nor is it known whether that proliferation is a regulated clonal expansion or merely a non-neoplastic hyperplasia. Human MCs display phenotypes that depend on the microenvironment. Thus, if the phenotype of MCs in mastocytosis lesions is determined to be abnormal for that tissue site (and therefore the MCs are refractory to microenvironmental signals) then a clonal process would be suggested. The authors determined the phenotypes of MCs from the lesional skin of 17 patients with indolent mastocytosis and the bone marrows of 9 patients. They compared them with the phenotypes of MCs from the lesional skin of 8 patients with various dermatitides, the skin of 2 patients with idiopathic anaphylaxis, and the breast skin of 15 control patients. MCs from all the skin specimens showed the characteristic skin MC phenotype, with predominantly scroll-poor granules by ultrastructure and containing tryptase and chymase by immunofluorescence detection (the MCTC immunophenotype). The skin MCs of each patient bound avidin and contained carboxypeptidase by immunofluorescence detection. MCs from the bone marrow of patients with indolent mastocytosis, the source of progenitors, also showed the scroll-poor and MCTC phenotypes. These findings do not support an unregulated clonal expansion in indolent forms of mastocytosis. They are consistent with a non-neoplastic hyperplasia or possibly a clonal process in which MCs remain responsive to microenvironmental regulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562049      PMCID: PMC1886368     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Conjugated avidin binds to mast cell granules.

Authors:  M D Tharp; L L Seelig; R E Tigelaar; P R Bergstresser
Journal:  J Histochem Cytochem       Date:  1985-01       Impact factor: 2.479

2.  Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells.

Authors:  L B Schwartz
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

3.  Two types of human mast cells that have distinct neutral protease compositions.

Authors:  A A Irani; N M Schechter; S S Craig; G DeBlois; L B Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Systemic mastocytosis. Extracutaneous manifestations.

Authors:  R D Brunning; R W McKenna; J Rosai; J L Parkin; R Risdall
Journal:  Am J Surg Pathol       Date:  1983-07       Impact factor: 6.394

5.  Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites.

Authors:  N Weidner; K F Austen
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

6.  Classification and diagnosis of mastocytosis: current status.

Authors:  D D Metcalfe
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

7.  Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease.

Authors:  R I Parker
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

8.  Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.

Authors:  R F Horan; K F Austen
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

9.  Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients.

Authors:  M D Fallon; M P Whyte; S L Teitelbaum
Journal:  Hum Pathol       Date:  1981-09       Impact factor: 3.466

10.  Tryptase from human pulmonary mast cells. Purification and characterization.

Authors:  L B Schwartz; R A Lewis; K F Austen
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

View more
  5 in total

Review 1.  Mast Cells and Anaphylaxis.

Authors:  Phil Lieberman; Lene Heise Garvey
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

2.  Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.

Authors:  N Haas; K Hamann; J Grabbe; B Algermissen; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 3.  Immunology and clinical manifestations of non-clonal mast cell activation syndrome.

Authors:  Juan-Carlos Cardet; Mariana C Castells; Matthew J Hamilton
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

4.  Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Peter Horny; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2021-01-25       Impact factor: 4.304

Review 5.  The role of mast cells in common gastrointestinal diseases.

Authors:  Ali A Siddiqui; Philip B Miner
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.